Rigel Pharmaceuticals (RIGL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2012 | 12-2011 | 09-2011 | 06-2011 | 03-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -23,174 | -85,973 | -60,186 | -42,255 | -20,781 |
| Depreciation Amortization | 552 | 1,955 | 1,429 | 923 | 447 |
| Accounts payable and accrued liabilities | 366 | 153 | -128 | 58 | -131 |
| Other Working Capital | -3,749 | 1,475 | -2,091 | -3,633 | -4,266 |
| Other Operating Activity | 2,732 | 13,015 | 10,255 | 6,979 | 3,968 |
| Operating Cash Flow | $-23,273 | $-69,375 | $-50,721 | $-37,928 | $-20,763 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 27,759 | -60,545 | -78,566 | -67,629 | 38,651 |
| PPE Investments | -1,574 | -2,303 | -2,118 | -1,557 | -860 |
| Investing Cash Flow | $26,185 | $-62,848 | $-80,684 | $-69,186 | $37,791 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | -800 | -666 | -485 | -251 |
| Common Stock Issued | 488 | 142,779 | 141,876 | 141,674 | 52 |
| Financing Cash Flow | $488 | $141,979 | $141,210 | $141,189 | $-199 |
| Beginning Cash Position | 18,633 | 8,877 | 8,877 | 8,877 | 8,877 |
| End Cash Position | 22,033 | 18,633 | 18,682 | 42,952 | 25,706 |
| Net Cash Flow | $3,400 | $9,756 | $9,805 | $34,075 | $16,829 |
| Free Cash Flow | |||||
| Operating Cash Flow | -23,273 | -69,375 | -50,721 | -37,928 | -20,763 |
| Capital Expenditure | -1,574 | -2,303 | -2,118 | -1,557 | -860 |
| Free Cash Flow | -24,847 | -71,678 | -52,839 | -39,485 | -21,623 |